Biotech

Latest Articles

Former Seagen CEO unveils new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for an im...

Ironwood creates more purpose $1B GI drug along with brand-new subgroup information

.On the heels of a phase 3 win that neglected to make an impression on real estate investors, Ironwo...

Novartis inks $150M deal for autoimmune molecular adhesive

.Don't stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizing...

Jade takes officer staff with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of significant management hirings, firings and ...

Septerna goes social along with upsized offering of $288M

.Commemorating his business's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the pos...

AbbVie creates Richter wealthier, paying $25M to constitute finding deal

.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar seeking anot...

GenSight gets into final weeks of cash money path as revenue stream edges out of scope

.GenSight Biologics is actually full weeks out of losing money. Once again. The biotech only possess...

AZ licenses discarded rare health condition medicine to Monopar Therapeutics

.Monopar Rehabs is recuperating a medication coming from the dump of AstraZeneca's rare illness pipe...

Arcus' brand new HIF-2a records in kidney cancer cells mean prospective advantage over Merck's Welireg, analysts state

.Along with new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of experts...

Roche bets up to $1B to grow Dyno gene therapy shipment pact

.After creating a gene treatment collaboration along with Dyno Therapeutics in 2020, Roche is actual...

Lundbeck slashes value of $250M Abide purchase after discomfort drawback

.Lundbeck is lowering the book market value of its own $250 million Abide Therapies purchase in reac...

Real- Planet Data Fulfills Medical Trial Layout: Optimizing Process and also Internet Site Choice

.The assimilation of real-world data (RWD) into method feasibility as well as site option has emerge...

Where are they right now? Overtaking past Intense 15 guest of honors

.At this year's Strong Biotech Peak in Boston, we caught up with innovators in the biotech business ...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 thousand ahead of time to purchase Yale spinout Modifi Bioscienc...

Radiopharma Alpha-9 raises $175M collection C to finance medical press

.Alpha-9 Oncology has increased a $175 thousand set C cycle to bankroll its clinical-stage radiophar...

Ocuphire to improve into gene treatment biotech via Opus purchase

.Eye medication creator Ocuphire Pharma is actually obtaining genetics therapy programmer Opus Genes...

Roche culls hack candidate, turns KRAS course in Q3 upgrade

.Roche's persistent cough system has actually sputtered to a standstill. The drugmaker, which axed t...

Merck- Gilead long-acting oral combo decreases HIV for 48 full weeks

.Gilead Sciences as well as Merck &amp Co. have actually helped their once-weekly HIV combo therapy ...

Lykos takes FDA watch that MDMA permission relies on new trial

.Lykos Rehabs may have lost three-quarters of its own workers back the FDA's turndown of its own MDM...

Septerna considers $158M IPO to finance readouts for GPCR pipe

.Septerna might be actually as yet to divulge "any relevant clinical data," however the biotech prec...